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A B S T R A C T
Cranberries and probiotics are individually considered as functional foods.This study evalu-
ated the potential synergy between bioactive proanthocyanidins (c-PAC) derived from
cranberries and probiotics on reducing the invasiveness of extra-intestinal pathogenic Es-
cherichia coli (ExPEC) in a cell culture model. ExPEC can be a component of the gut microbiota
in healthy individuals, and reducing the invasiveness of ExPEC is a potential means to lessen
the risk of subsequent urinary tract infections (UTI), the most common bacterial infec-
tions in women. c-PAC (>92 %A-type) concentrations greater than 36 µg c-PAC/mL significantly
(p < 0.05) reduced ExPEC invasion, and was not inhibited by the presence of probiotics. Scan-
ning electronmicroscopy suggests that themechanism by which c-PAC prevent ExPEC invasion
is by cross-linking surface virulence factors. A probiotic blend also significantly reduced in-
vasion, albeit via a different mechanism. This study demonstrated the potential benefit of
combining functional A-type c-PAC components in cranberry foods with probiotics.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the
CC BY license (http://creativecommons.org/licenses/by/4.0/).
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1. Introduction
Functional foods continue to grow in popularity as consum-
ers seek benefits from food products that go beyond basic
nutrition.A central component of an efficacious functional food
is the presence of biologically active compounds, and study-
ing the interplay of these biologically active compounds when
combined in a finished functional food product is central to
understanding mechanisms. The focus of this study was on
the combination of cranberry-derived proanthocyanidins (Fig. 1)
and probiotic bacteria, as although each brings with them strong
science, the combination has not been evaluated mechanis-
tically as it relates to feminine health.
It is well known that the human body hosts microorgan-
isms that inhabit surfaces having a connection to the external
environment. A study of varied microbial communities that
inhabit the gut, skin, and vagina of the human body has
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revealed wide heterogeneity even amongst healthy individu-
als (Human Microbiome Project Consortium, 2012). Vaginal
bacterial communities have recently been characterized across
four ethnic groups of North American women, with the vaginal
microbial communities clustering into five groups (Ravel et al.,
2011). Four groups are dominated by Lactobacillus sp., and all
groups share the trait of lactic acid production, which appears
to be a key conserved function associated with vaginal health
(Ma, Forney, & Ravel, 2012).
The homeostasis of the vaginal microbial ecosystem is im-
portant for maintaining vaginal health. Urinary tract infections
(UTIs) are the most common infections affecting women, and
is an acute bacterial infection occurring when pathogens colo-
nize the vagina and ascend into the urinary system (Valiquette,
2001). The most common vaginal syndrome afflicting fertile,
premenopausal and pregnant women is bacterial vaginosis (BV)
(Mastromarino, Vitali, & Mosca, 2013). BV is a complex disor-
der characterized by an overgrowth of strict or facultative
anaerobic bacteria and importantly, a reduction of lactoba-
cilli (Lamont et al., 2011). In addition to causing significant
morbidity and health care costs annually, the standard care
is clinically prescribed antibiotic prophylaxis; however, the long-
term use of antibiotics is associated with several side effects
including vaginal itching, skin rash, and or nausea (Albert et al.,
2004). Additionally, there is a concern gaining attention re-
garding antibiotic use and permanent changes to the resident
microflora having serious consequences (Blaser, 2011).
Probiotics are livemicroorganisms that,when administered
in adequate amounts, confer a health benefit on the host (Hill
et al., 2014). Specific strains of probiotics have been demon-
strated tobedelivered to thevagina followingoral administration,
aswell ashelp resolve asymptomatic BVor intermediate BV (Reid
et al., 2001). A variety of commercial probiotic Lactobacillus sp.
havebeenshownto inhibit thegrowthanddisplaceuropathogenic
Escherichia coli (UPEC) in vitro (Delley et al., 2015).
Other natural therapies used tomaintain urogenital health
include cranberry extracts or powders, and although the data
are difficult to compare due to the lack of cranberry standard-
ization, meaningful benefits have been achieved (Ledda et al.,
2015). More specifically, recent data have demonstrated that
the ratio of“A-type”to“B-type”proanthocyanidins (c-PAC)derived
from cranberries has an effect on the ability of extra-intestinal
pathogenic E. coli (ExPEC) to invade gut epithelial cells (Feliciano,
Krueger, & Reed, 2015; Feliciano, Meudt, Shanmuganayagam,
Krueger, & Reed, 2014; Krueger, Reed, Feliciano, & Howell, 2013;
Rodriguez-Mateos et al., 2014). Investigations into ExPEC ad-
herence to host tissue show that the primary adherence factors
of E. coli are supramolecular filamentous adhesive organelles
known as fimbriae (Sharon & Ofek, 2002). It is hypothesized
that c-PAC may act by obstructing strains of E. coli from ad-
hering to epithelial cells after treatmentwith cranberry products
(Gupta et al., 2007).Although the exactmechanism is not known,
c-PACs have been shown to bind E. coli and render them
nonadherent,possibly by attaching to fimbrial tips (Howell, 2007)
thus diminishing their adhesiveness,which affects the first step
in the invasion process (Liu et al., 2008). This study evaluated
the potential synergies of two functional food products, namely
probiotics and c-PAC derived from cranberry powder, on re-
ducing the invasiveness of an ExPEC.
The objective of the studies presented here was to deter-
mine if c-PAC alone, probiotic formulations alone, or probiotic
formulations in combination with c-PAC could inhibit the ability
of ExPEC to invade epithelial cells in an in vitro Caco-2 cell
culture model.
Fig. 1 – Representative structure of an anthocyanin linked to a c-PAC dimer through an ethyl group. Variation in number of
A-type versus B-type interflavan bonds, degree of polymerization, position, and substitutions with anthocyanins leads to
large structural heterogeneity among c-PAC oligomers.
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2. Materials and methods
2.1. Preparation and characterization of PAC
One hundred grams of organic cranberry powder (Fruit d’Or
11N00037) was extracted with 70% aqueous acetone (v/v, 400mL)
in an ultrasonic bath for 15 minutes, centrifuged at 400 × g at
15 °C for 10 minutes and the supernatant was collected. The
extraction was repeated two additional times, and the super-
natants were combined. After filtration with cellulose paper,
acetone was removed by rotary evaporation under vacuum at
35 °C. The remaining aqueous solution was applied to a
Sephadex LH-20 column (equilibrated in ethanol). The column
was eluted sequentially with ethanol and 50% (v/v) ethanol/
methanol to remove hydroxycinnamic acids, anthocyanins, and
flavonols. The resin was then eluted with 70% (v/v) aqueous
acetone to recover c-PAC.
2.2. Quantitation of soluble c-PAC
The 4-(dimethylamino) cinnamaldehyde (DMAC) assaywasused
toquantify c-PAC.4-(Dimethylamino)cinnamaldehyde reactswith
flavan-3-ols and PAC to form a green chromophore that has a
maximum absorbance at approximately 640 nm. The reaction
appears to be limited to the C8 position of theA-ring of PAC ter-
minal units; therefore,as degree of polymerization (DP) increases,
molar absorptivity decreases (Feliciano et al., 2012). The con-
centrations of c-PAC used in these experiments are reported as
c-PAC Equivalents (µg c-PAC/mL) as determined by the DMAC
method.The c-PAC standard used in the assay is a standard ref-
erencematerial that was produced fromwhole cranberries and
is reflective of the natural diversity of cranberry polyphenols and
their polymer distribution.
2.3. Characterization of c-PAC standard
Previously developed MALDI-TOF MS methods (Feliciano,
Krueger, Shanmuganayagam, Vestling, & Reed, 2012; Feliciano
et al., 2014) were applied to characterize soluble c-PAC. An
aliquot of the extract was evaporated to dryness and sus-
pended in ethanol to a final concentration of approximately
20 mg/mL. An aliquot (0.5 µL) of this sample was mixed with
1 µL of DHB (50.0 mg/mL in ethanol) and placed in three dif-
ferent wells on the stainless steel MALDI target. Mass spectra
were collected on a Bruker ULTRAFLEX-III MALDI-TOF/TOF (Bil-
lerica, MA, USA), equipped with a Smart Beam™, a two-stage
gridless reflection, and a LIFTTM cell. Mass spectra acquired
in positive reflectron mode are the sum of spectra from dif-
ferent locations in each well with the deflection set at 550.
Compass™ v1.3 software controlled the instrument. An inter-
nal laboratory standard cranberry PAC preparation was used
for calibration as previously described (Feliciano et al., 2012).
FlexControl and FlexAnalysis (Bruker Daltonik GmbH, Bremen,
Germany, version 3.0) were used for data acquisition and data
processing, respectively.
2.4. Cell culture
Caco-2 (HTB-37) cells were cultured in DMEM supplemented
with 10% FBS, 1% non-essential amino acids, 1% L-alanyl-L-
glutamine, and 1% penicillin (100 units/mL)/streptomycin
(100 µg/mL) at 37 °C in 5% CO2. For use in cell invasion experi-
ments, cells were seeded at 80% confluency into 24-well tissue
culture treated plates. Once the cells reached confluence (after
4 days), they were allowed to differentiate for 8 days (12 days
post seeding) to become phenotypic polarized enterocytes.
2.5. Bacterial strains and growth conditions
The ExPEC strain (E. coli ExPEC Strain-5011) used in our studies
was isolated from a clinical faecal sample and characterized
to be genotypically representative of ExPECs. The strain ex-
presses both P and type 1 fimbriae. To aid in the selection of
the strain (over the probiotic strains used in the co-cultured
invasion assay), the microbe was transformed to constitu-
tively express luciferase (Lux) using a highly stable, custom low-
copy plasmid, pGEN-Lux, with resistance to ampicillin (Pierre
et al., 2013).The ampicillin-resistant ExPECwas cultured under
static conditions in 40 mL tryptose broth (10 g tryptose, 2.5 g
sodium chloride, 0.5 g dextrose, and 0.0025 g thiamine hydro-
chloride in 500mLofdeionizedwaterwith 100mg/mLampicillin)
for 48 h at 37 °C. After 48 hours of growth, 1 mL of culture was
taken from the surface of the culture and used to inoculate a
new culture grown under static conditions for 24 h at 37 °C.
This culturing procedure optimizes the expression of viru-
lence factors.Thefiveprobiotic strainsused in these experiments
were obtained from UAS Laboratories LLC: Lactobacillus gasseri
UALg-05 (L.g.), Bifidobacterium animalis subsp. lactis UABla-12 (B.
lac.), Lactobacillus plantarum UALp-05 (L.pl.), Lactobacillus aci-
dophilusDDS®-1 (L.a.), and L. rhamnosusUALrh-18 (L.rh.).Cultures
were inoculated into 40 mL MRS broth with/0.05% L-cysteine
and allowed to incubate statically at 37 °C overnight (16 hours).
Absorbance was measured and bacteria quantified using pre-
viously established growth curves, as outlined below, prior to
inclusion as treatments in microbial invasion studies.
On the day of invasion assays, cultures were centrifuged at
1800 × g for 10 minutes to obtain a bacterial pellet. The pellet
was washed twice in 40 mL PBS and then re-suspended in 1 mL
PBS to obtain the bacterial stock solution used in experi-
ments.The CFU/mL of the ExPEC stock solution was determined
by obtaining the optical density on a spectrophotometer
(DU640B; Beckman, Brea, USA) at 450 nm and plotting it against
previously established growth curves (Pierre et al., 2013).
2.6. Bacterial growth curves
For each probiotic strain, a culture was inoculated into 40 mL
MRS broth with 0.05% L-cysteine and allowed to incubate stati-
cally at 37 °C overnight (16 hours). Cultures were centrifuged
at 1800 × g for 10 minutes to obtain a bacterial pellet and then
washed twice with PBS. Cell pellets were suspended in 10 mL
PBS, serially diluted and absorbance read (450 nm). Serial di-
lutions were plated on MRS agar plates with/0.05% L-cysteine
and CFUs were enumerated after overnight growth at 37 °C.
Absorbance values were regressed against CFUs for the estab-
lishment of growth curves for each strain of bacteria.
2.7. Invasion assay
ExPEC was cultured as described previously in this section to
reach amultiplicity of infection (MOI) of 100 (8.0 × 107 CFU/well)
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relative to the number of Caco-2 cells (8.0 × 105 cells/well). For
each series of experiments described below, 25 µL of treatment
were added to 25 µL of ExPEC yielding a total volume of 50 µL.
The solutionwasgentlymixedand then incubated for 10minutes
at 37 °C. After 10 minutes, 22.5 µL of treatment + ExPEC
mixture were added to 727.5 µL of Invasion Media (DMEM
supplementedwith 10% FBS, 1% non-essential amino acids, 1%
L-alanyl-L-glutamine) and allowed to incubate at 37 °C for 5
minutes.After 5minutes, differentiated Caco-2 cell plates were
washed twice with 1 × D-PBS + Ca2+/Mg2+, and 0.5 mL of each
c-PAC + bacteria treatment mixture was added to the differen-
tiatedCaco-2cell plates inquadruplicate.Treatmentswereallowed
to incubate for 1 h at 37 °C to allow for bacterial invasion after
which, Caco-2 cells were washed twice with 1 × D-PBS + Ca2+/
Mg2+, and extracellular bacteria were killed by incubating 1 mL
of InvasionMedia supplementedwith gentamicin at a final con-
centration of 100 µg/mL for 1 h at 37 °C. Caco-2 cells were then
washed twicewithD-PBS (without Ca2+ andMg2+) and lysedwith
1 mL/well 1%Triton X-100 (Sigma) for 30 min on a shaker.After
intracellular bacteriawere released fromCaco-2 cells, eachwell
contentwashomogenized via pipetting anddiluted 1:10 inD-PBS
(without Ca2+ and Mg2+), and 100 µL of lysate was plated in du-
plicate on LB-amp plates (25 g LB Miller, 15 g of agar in 1 L of
deionized water, 100 µg/mL ampicillin). All plates were incu-
bated for 18 hat37 °C,and thenumberofCFUs/platewascounted.
All series of experiments (outlined below) were repeated twice
(2 separate days), and four replicates of each treatmentwere per-
formed on eachplate for a total of 8 treatment replicates.Results
are presented as the average of all replications normalized to a
control treatment.
2.8. Invasion assay – dose dependent effect of
c-PAC alone
When assessing the effects of c-PAC alone on cell invasion, we
mixed the ExPEC with c-PAC at various concentrations.Twenty-
five microlitres of D-PBS + Ca2+/Mg2+ or c-PAC treatments (0, 4,
9, 18, 36, 71, 142, and 285 µg c-PAC/mL) were added to a total
volume of 50 µL, gently mixed, and then incubated for 10
minutes and added to Caco-2 cells as described above.
2.9. Invasion assay – dose dependent effect of
L. acidophilus alone
When assessing the effects of L. acidophilus alone on cell in-
vasion, wemixed the ExPEC with the probiotic strain and added
to Caco-2 cells as described above. For convenience, we adopted
the same convention, multiplicity of infection (MOI), for re-
ferring to the number of probiotic cells introduced as treatments
into the invasion study. The use of MOI in this sense does not
infer that probiotics invade enterocytes, but simply provides
a ratio of probiotics per Caco-2 cell. The MOI for L. acidophilus
treatments were 25, 50, 100, 200, and 400.
2.10. Invasion assay – dose dependent effect of
L. acidophilus in combination with c-PAC
When assessing the effects of L. acidophilus (MOI = 100) plus
c-PAC (18, 36, 71 µg c-PAC/mL) on cell invasion, we pre-
incubated the ExPEC for 5 minutes with c-PAC prior to adding
the probiotic treatment. Incubation with Caco-2 cells was per-
formed as described above.
2.11. Invasion assay – dose dependent effect of 5 strain
probiotic blend in combination with c-PAC
When assessing the effect of a 5 strain probiotic blend con-
sisting of L. acidophilus, L. gasseri, L. plantarum, L. rhamnosus and
B. animalis subsp. lactis in equal proportion (MOI = 100) plus c-PAC
(18, 36, 71 µg c-PAC/mL) on cell invasion,we incubated the ExPEC
for 5 minutes with c-PAC prior to adding the 5 strain probiotic
blend treatment. Incubation with Caco-2 cells was performed
as described above.
2.12. Invasion assay – dose dependent effect of 5 strain
probiotic blend as pre-treatment
When assessing the dose dependent effect of a 5 strain probiotic
blend pre-treatment consisting of L. acidophilus, L. gasseri,
L. plantarum, L. rhamnosus and B. animalis subsp. lactis on cell
invasion, we mixed the probiotic blend with the Caco-2 cells
for 1 hour before the addition of ExPEC. The MOI treatments
for the probiotic blend pre-treatments were 0, 100, 200, and 400.
ExPEC incubation with Caco-2 cells pre-treated with the
probiotic blend was performed as described above.
2.13. Scanning electron microscopy
Bacteria were cultured as described previously in this section
to reach a concentration of 8.0 × 107 CFU/well. Twenty-five
microlitres of D-PBS + Ca2+/Mg2+ or c-PAC treatment (71 µg c-PAC/
mL) were added to a total volume of 50 µL, gently mixed, and
then incubated for 10 minutes. After 10 minutes, 22.5 µL of
c-PAC + bacteria treatment mixture was added to 727.5 µL of
D-PBS + Ca2+/Mg2+ and allowed to incubate at 37 °C for 5minutes.
After 5minutes,0.5mLofeachc-PAC + bacteria treatmentmixture
was passed through a 0.45 µmsilvermembrane filter (Steritech
#45329). Immediately after themixturewas passed through the
filter, 1 mL of 3% glutaraldehyde was passed through the filter
to fix the bacteria.The silver membrane filters were then left in
3% glutaraldehyde for 16 hours. The filters were then dehy-
drated with 15 minutes/series through an ethanol series using
the following percentages: 30, 50, 70, 80, 90, 95, 100(×2).The filters
were then 100% Sieve dried.The filters were dried via the criti-
cal point procedure (10 minutes × 3 soaks) and adhered to
aluminiumSEMspecimen stubswith double-sided carbon sticky
tabs. The filters were then sputter coated with a ~25 nm layer
of gold/palladium. SEM images were acquired with a Hitachi
S-3200N using an accelerating voltage at 5–10 keV.
3. Results
3.1. Characterization of c-PAC by MALDI-TOF MS
The soluble c-PAC extract of the organic cranberry powder use
in these studies reflects the structural heterogeneity of c-PAC
oligomers (degree of polymerization, nature of hydroxyl sub-
stitution and nature of interflavanyl linkages) found in cranberry
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fruits. Deconvolution of the MALDI-TOF mass spectral isotope
patterns at each degree of polymerization from 3 (trimer) to
7 (septamer) by the method of Feliciano et al. (2012, 2014) shows
that >92% of cranberry PAC oligomers contained one or more
“A-type” interflavanyl bonds (Fig. 2; Table 1).
3.2. Invasion assay – dose dependent effect of c-PAC alone
Soluble cranberry proanthocyanidins (c-PAC), in a dose depen-
dent manner (>36 µg c-PAC/mL), inhibited the ability of ExPEC
to invade enterocytes in this Caco-2 cell culture model. c-PAC
at a concentration of greater than 36 µg c-PAC/mL signifi-
cantly (p < 0.05) reduced invasion relative to control (Fig. 3).
Results indicate that there is a threshold between 18 and 36 µg
c-PAC/mL at which c-PAC shows anti-invasive activity. These
results are in agreement with previously published work de-
scribing c-PAC increasing ExPEC agglutination and decreasing
ExPEC invasion of epithelial cells (Feliciano et al., 2014, 2015;
Krueger et al., 2013).
3.3. Invasion assay – dose dependent effect of
L. acidophilus alone
L. acidophilus (MOI = 25, 50, 100, 200, 400) was evaluated for anti-
invasion activity. Results indicate that under the conditions of
this assay, L. acidophilus alone did not significantly affect in-
vasion of ExPEC at any concentration tested (Fig. 4). Observation
of the L. acidophilus incubation (1 hour) with the Caco-2 cells
in the presence of ExPEC challenge indicate that the pH of the
cell culture environment becomes increasingly acidic, in a dose
dependent (increasing probiotic MOI) manner, as is evident by
the changing in colour of the pH indicator (phenol red) used
in the cell culture media to monitor levels of CO2. This lower
pH would be expected for an active culture of L. acidophilus.
While the accumulation of acid at these particular treatment
levels was not great enough to warrant concern over integ-
rity of Caco-2 cells over the course of a one-hour incubation
period, it is informative of potential environmental factors that
may affect the cell culture model if higher doses (MOI) or longer
incubation periods were evaluated. Furthermore, the in-
crease in acidity also indicates a possible environmental
(intestinal lumen) mechanism for probiotic antagonism that
should be considered in future translational animal and or
human clinical studies.
3.4. Invasion assay – dose dependent effect of
L. acidophilus in combination with c-PAC
The study results summarized in Fig. 3 informed us that c-PAC
at 36 µg c-PAC/mL alone reduced ExPEC invasion by 80.8% rela-
tive to control.The study results, summarized in Fig. 4, informed
us that there was no significant anti-invasion effect of L. aci-
dophilus alone, and without any preincubation, at any of the
treatment levels. For the next experiment evaluating syner-
gistic effects of probiotics + c-PAC, we chose to use a MOI = 100
for both the ExPEC and the L. acidophilus, as well as c-PAC levels
of 18, 36 and 71 µg c-PAC/mL.The results in Fig. 5 indicate that
L. acidophilus (MOI = 100) + c-PAC at 71 µg c-PAC/mL signifi-
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Fig. 2 – Deconvolution of MALDI-TOF positive reflectron mode mass spectra. Relative percentage of proanthocyanidins that
contain one or more A-type interflavan bonds at degree of polymerization (DP) between trimer (3) and heptamer (7).
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cantly (p < 0.05) inhibited ExPEC invasion of enterocytes relative
to control. Results also indicate that L. acidophilus (MOI = 100) + c-
PAC at 36 µg c-PAC/mL inhibited invasion of enterocytes by 69.1%
relative to control; however, this was not significant due to the
large standard deviation. Taken at a minimum, the combina-
tion of L. acidophilus and c-PAC did not encumber the anti-
invasiveness of c-PAC.
3.5. Invasion assay – dose dependent effect of 5 strain
probiotic blend in combination with c-PAC
We next chose to test c-PAC at 18, 36 and 71 µg c-PAC/mL plus
a 5 strain probiotic blend consisting of Lactobacillus species
commonly isolated from healthy vaginal cavities and a
Bifidobacterium species with human clinical documentation. Spe-
cifically, the blend comprised L. acidophilus, L. gasseri, L. plantarum,
L. rhamnosus and B. animalis subsp. lactis, in a ratio of equal pro-
portions (MOI = 100). Results indicate that the probiotic blend
(MOI = 100) + c-PAC at both 36 and 71 µg c-PAC/mL signifi-
cantly (p < 0.05) inhibited ExPEC invasion of enterocytes relative
to control (Fig. 6).
It should be noted that while experimental details de-
scribed in Fig. 3 informed us that c-PAC at 36 µg c-PAC/mL
significantly reduced ExPEC invasion relative to control, in this
study the same dose (used as a positive control) did not sig-
nificantly inhibit ExPEC invasion relative to control. Results
indicate that the 5 strain probiotic blend, when combined with
c-PAC (36 µg c-PAC/mL), has better anti-invasion activity than
the c-PAC (36 µg c-PAC/mL) alone. This trend was also seen in
L. acidophilus as the only probiotic with c-PAC; however, because
of large standard deviation, those results were not statisti-
cally significant.
3.6. Invasion assay – dose dependent effect of 5 strain
probiotic blend as pre-treatment
Thus far, these sets of experiments informed us that there
was no significant anti-invasion effect of L. acidophilus alone
at any of the treatment levels when studied under the condi-
tions of the assay. However, in the intestinal lumen, it is
thought that the ExPEC would encounter actively metaboliz-
ing cells in an environment of bacterial metabolites, much
different than the conditions of this assay. Therefore, it is
possible that any potential in vivo synergies may be artifi-
cially missed due to the experimental set-up. For the next
experiment, we again used a 5 strain probiotic blend consist-
ing of L. acidophilus, L. gasseri, L. plantarum, L. rhamnosus and
B. animalis subsp. lactis in equal proportions. In addition, the
5-strain probiotic blend was added at different concentra-
tions (MOI = 100, 200, and 400) to the Caco-2 cells one hour
(pre-incubation) prior to a challenge with the ExPEC. No c-PAC
was incorporated in this experiment. Results indicate that
the 5 strain probiotic blend at MOI = 400 significantly (p < 0.05)
inhibited ExPEC invasion of enterocytes relative to control
(Fig. 7). The difference in this outcome compared to Fig. 4
may be attributed to either the blend of the 5 probiotic strains
or the additional one-hour pre-incubation period that pre-
ceded the ExPEC challenge.
Observation of the 5 strain probiotic blend (1-hour pre-
incubation + 1-hour incubation in presence of ExPEC) with the
Caco-2 cells again indicated, in a dose dependent (increasing
probiotic MOI) manner, that the pH of the cell culture envi-
ronment becomes increasingly acidic, as was evident by the
yellowing of the media via the pH indicator (phenol red). The
accumulation of acid in the treatments with higher numbers
of probiotic strains coupled with longer incubation time for in-
vasion may affect the cell culture model if higher doses (MOI)
or longer incubation periods are evaluated. Furthermore,
changes in luminal pH may also be a possible mechanism that
should be studied in translational animal and or human clini-
cal studies.
3.7. Scanning electron microscopy
Scanning electron micrographs were captured to help visual-
ize the structure–activity mechanism by which cranberry
c-PACs interact with ExPEC (UTI pathogen) and with
Table 1 – Relative percentage of A-type to B-type
interflavan bonds. Deconvolution of MALDI-TOF positive
reflectron mode mass spectra indicate that the
predominant proanthocyanidin structure at each degree
of polymerization (trimer through heptamer) contains
one or more A-type interflavan bonds.
TRIMERS
Linkage Type Relative Percentage
2A-type: 0B-type 6.7%
1A-type: 1B-type 88.1%
0A-type: 2B-type 5.1%
TETRAMERS
Linkage Type Relative Percentage
3A-type: 0B-type 4.0%
2A-type: 1B-type 15.5%
1A-type: 2B-type 72.1%
0A-type: 3B-type 8.4%
PENTAMERS
Linkage Type Relative Percentage
4A-type: 0B-type 0.0%
3A-type: 1B-type 4.2%
2A-type: 2B-type 30.9%
1A-type: 3B-type 54.4%
0A-type: 4B-type 10.5%
HEXAMERS
Linkage Type Relative Percentage
4A-type: 1B-type 0.0%
3A-type: 2B-type 7.8%
2A-type: 3B-type 48.3%
1A-type: 4B-type 36.2%
0A-type: 5B-type 7.6%
HEPTAMERS
Linkage Type Relative Percentage
4A-type: 2B-type 0.0%
3A-type: 3B-type 18.4%
2A-type: 4B-type 48.1%
1A-type: 5B-type 40.7%
0A-type: 6B-type 0.0%
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Fig. 3 – c-PAC without probiotic. Dose response effect (normalized to control) of soluble cranberry proanthocyanidin (c-PAC)
on the ability of ExPEC to invade Caco-2 cells, expressed in µg c-PAC/mL as quantified by the DMAC method. * denotes
p<0.05 compared to no c-PAC.
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Fig. 4 – Lactobacillus acidophilus without c-PAC. Dose response effect (normalized to control) of Lactobacillus acidophilus on
the ability of ExPEC to invade Caco-2 cells, expressed as ratio of Lactobacillus acidophilus per Caco-2 cell.
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Fig. 5 – Lactobacillus acidophilus with c-PAC. Dose response effect (normalized to control) of cranberry proanthocyanidin (c-
PAC) plus Lactobacillus acidophilus (MOI=100) on the ability of ExPEC to invade Caco-2 cells. * denotes p<0.05 compared to no
c-PAC and no L. acidophilus treatment.
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Fig. 6 – Probiotic blend with c-PAC. Dose response effect (normalized to control) of soluble proanthocyanidin (c-PAC) plus a 5
strain probiotic blend consisting of Lactobacillus acidophilus, Lactobacillus gasseri, Lactobacillus plantarum, Lactobacillus
rhamnosus and Bifidobacterium animalis subsp. lactis in an equal proportion (MOI=100) on the ability of ExPEC to invade
Caco-2 cells. * denotes p<0.05 compared to no c-PAC and no probiotic blend.
130 J o u rna l o f Func t i ona l F ood s 2 5 ( 2 0 1 6 ) 1 2 3 – 1 3 4
L. acidophilus (probiotic). These results are summarized in
Fig. 8. Fig. 8A shows ExPEC alone and the agglutination effect
when ExPEC is combined with c-PAC (Fig. 8B). Like ExPEC, the
L. acidophilus was imaged without c-PAC (Fig. 8C), but unlike
ExPEC, is not agglutinated in the presence of c-PAC (Fig. 8D).
The combination of ExPEC and L. acidophilus without (Fig. 8E),
and in combination with c-PAC, was also evaluated and
demonstrated the selective agglutination of ExPEC with c-PAC
(Fig. 8F).
4. Discussion
UTIs are the most common bacterial infections in women, with
one half of all women experiencing at least one UTI in their
lifetime (Vicariotto, 2014). One of the primary causative
agents of UTIs is ExPEC, where the organism may be a com-
ponent of the gut microbiota in healthy individuals, but when
gaining access to niches outside the gut, can colonize these
niches and cause disease (Wiles, Kulesus, & Mulvey, 2008).
Natural approaches to traditional pharmaceutical treat-
ments forUTIsandbacterial vaginosishavegainedmoreattention
due to the high recurrence rates resulting in repeated drug ex-
posure. Probiotics have been evaluated for a variety of
gastrointestinal benefits (Ritchie & Romanuk, 2012) as well as
benefits outside the gastrointestinal tract, including recurrent
urinary tract infections (Grin, Kowalewska, Alhazzan, &
Fox-Robichaud, 2013) andbacterial vaginosis (Mastromarinoet al.,
2013). Studies on selected probiotics (Lactobacillus sp.) have dem-
onstrated thatorally ingestedprobiotics canbe found in thevagina
(Reid et al., 2001) and trials evaluating the efficacy of probiotics
against bacterial vaginosis (Mastromarino et al., 2013) and
urinary tract infections (Grin et al., 2013) have been recently re-
viewed.The effectiveness of selected probiotics against bacterial
vaginosis, whether administered orally or intra-vaginally, and
in combination with antibiotics or not, has provided promising
data that require additional studies (Mastromarino et al., 2013).
A recent meta-analysis comparing results from existing ran-
domized clinical trials evaluating Lactobacillus species and
recurrentUTI did indicate a significant decrease in recurrentUTI
incidence inpremenopausalwomen (Grin et al., 2013; Schwenger,
Tejani, & Loewen, 2015).
The microbiota of the vaginal cavity has been evaluated
usingmolecular techniques, and the consensus for most healthy
women appears to be that a healthy microbiota is dominated
by Lactobacillus species (Lamont et al., 2011; Ravel et al., 2011).
However, there are significant numbers of healthy women that
lack significant numbers of vaginal lactobacilli (Lamont et al.,
2011). Probiotics have been evaluated following oral consump-
tion along with antimicrobial therapy for their impact on the
vaginal microbiota (Macklaim, Clemente, Knight, Gloor, & Reid,
2015). In women with a healthy vaginal microbiota, probiotic
therapy along with antibiotic therapy did not appreciably change
the microbiota, but in women with bacterial vaginosis, treat-
ment with probiotics and the antibiotic therapy did increase
the abundance of indigenous Lactobacillus sp. (Macklaim et al.,
2015).
Cranberry juice, powder and extracts have been con-
sumed for decades to relieve symptoms of and prevent
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Fig. 7 – Probiotic blend pre-incubation. Effect (normalized to control) of increasing MOI of a 5 strain probiotic blend
consisting of equal proportions of Lactobacillus acidophilus, Lactobacillus gasseri, Lactobacillus plantarum, Lactobacillus
rhamnosus and Bifidobacterium animalis subsp. Lactis on the ability of ExPEC to invade Caco-2 cells. * denotes p<0.05
compared to no pre-incubation.
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recurrent UTI. The functional food compounds in cranberries
are c-PAC, specifically c-PAC containing A-type interflavan
bonds. It has been reported that c-PAC are not absorbed, and
that their health benefits in relation to UTI most likely occur
at mucosal surfaces of the gastrointestinal tract (Feliciano et al.,
2015; Krueger et al., 2013; Rodriguez-Mateos et al., 2014). c-PACs
have been shown to effectively agglutinate ExPEC and inhibit
the ability of ExPEC to invade epithelial cells providing a mecha-
nistic understanding of how c-PAC interact with pathogenic
microbes in specific structure–function relationships (Feliciano
et al., 2015). In this study, we demonstrate that c-PACs (>92%
A-type) have a specific affinity for ExPEC that enables their ag-
glutination and thus weakens their ability to invade epithelial
cells. This interaction is not observed between c-PAC and
probiotics, indicating a structure–activity mechanism unique
to ExPEC that we think is attributable to the presence of ad-
hesion molecules (fimbriae) specific to ExPEC.
In conclusion, this pilot study provides insight on the po-
tential mechanistic role of the combination of (a) probiotics
selected from common vaginal inhabitants along with (b) c-PAC
BA
C
E
D
F
Fig. 8 – SEM images. A) ExPEC B) ExPEC + c-PAC C) L. acidophilus D) L. acidophilus + c-PAC E) ExPEC + L. acidophilus F) ExPEC +
L. acidophilus + c-PAC.
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from high quality cranberry powder, on inhibiting the inva-
siveness of ExPEC. The study of these bioactive compound
combinations is important to facilitate the development of
future functional foods. The ability of c-PAC to agglutinate/
bind the ExPEC was not inhibited by the probiotic component.
This observation is primarily attributed to the presence of ad-
hesive organelles on the surface of ExPEC but not on the surface
of L. acidophilus. The probiotic combination was shown to be
anti-invasive when pre-incubated, indicating that probiotics
may contribute to providing an inhospitable environment of
ExPEC in the gastrointestinal tract. Clearly, further studies are
needed to confirm these in vitro findings in an in vivo system,
but this study provides evidence that rationale product design
by combining synergistic functional food ingredients may have
a role in promoting health in targeted applications.
Conflict of interest
The authors declare the following competing financial inter-
est(s): Christian G. Krueger and Jess D. Reed have ownership
interest in Complete Phytochemical Solutions, LLC, and in full
disclosure their affiliation with this company is acknowl-
edged in the author affiliation.
Acknowledgements
We thank Fruit d’Or for providing the organic cranberry powder
for these studies, UAS Laboratories, LLC for providing probiotic
strains and Dr.Walt Hopkins of the University ofWisconsin-–
Madison for kindly providing E. coli strain 5011.We would also
like to thank Fikrullah Kisa for his assistance with SEM image
preparation.
R E F E R E N C E S
Albert, X., Huertas, I., Pereiro, I. I., Sanfelix, J., Gosalbes, V., &
Perrota, C. (2004). Antibiotics for preventing recurrent urinary
tract infection in non-pregnant women. The Cochrane Database
of Systematic Reviews, (3), CD001209. doi:10.1002/
14651858.CD001209.pub2.
Blaser, M. (2011). Antibiotic overuse: Stop the killing of beneficial
bacteria. Nature, 476(7361), 393–394. doi:10.1038/476393a.
Delley, M., Bruttin, A., Richard, M., Affolter, M., Rezzonico, E., &
Bruck, W. M. (2015). In vitro activity of commercial probiotic
Lactobacillus strains against uropathogenic Escherichia coli.
FEMS Microbiology Letters, 362(13), fnv096. doi:10.1093/femsle/
fnv096.
Feliciano, R. P., Krueger, C. G., & Reed, J. D. (2015). Methods to
determine effects of cranberry proanthocyanidins on
extraintestinal infections: Relevance for urinary tract health.
Molecular Nutrition & Food Research, 59(7), 1292–1306.
doi:10.1002/mnfr.201500108.
Feliciano, R. P., Krueger, C. G., Shanmuganayagam, D., Vestling, M.
M., & Reed, J. D. (2012). Deconvolution of matrix-assisted laser
desorption/ionization time-of-flight mass spectrometry
isotope patterns to determine ratios of A-type to B-type
interflavan bonds in cranberry proanthocyanidins. Food
Chemistry, 135(3), 1485–1493. doi:10.1016/
j.foodchem.2012.05.102.
Feliciano, R. P., Meudt, J. J., Shanmuganayagam, D., Krueger, C. G.,
& Reed, J. D. (2014). Ratio of “A-type” to “B-type”
proanthocyanidin interflavan bonds affects extra-intestinal
pathogenic Escherichia coli invasion of gut epithelial cells.
Journal of Agricultural and Food Chemistry, 62(18), 3919–3925.
doi:10.1021/jf403839a.
Feliciano, R. P., Shea, M. P., Shanmuganayagam, D., Krueger, C. G.,
Howell, A. B., & Reed, J. D. (2012). Comparison of isolated
cranberry (Vaccinium macrocarpon Ait.) proanthocyanidins to
catechin and procyanidins A2 and B2 for use as standards in
the 4-(dimethylamino)cinnamaldehyde assay. Journal of
Agricultural and Food Chemistry, 60(18), 4578–4585. doi:10.1021/
jf3007213.
Grin, P. M., Kowalewska, P. M., Alhazzan, W., & Fox-Robichaud, A.
E. (2013). Lactobacillus for preventing recurrent urinary tract
infections in women: Meta-analysis. The Canadian Journal of
Urology, 20(1), 6607–6614.
Gupta, K., Chou, M. Y., Howell, A., Wobbe, C., Grady, R., &
Stapleton, A. E. (2007). Cranberry products inhibit adherence
of p-fimbriated Escherichia coli to primary cultured bladder
and vaginal epithelial cells. The Journal of Urology, 177(6), 2357–
2360. doi:10.1016/j.juro.2007.01.114.
Hill, C., Guarner, F., Reid, G., Gibson, G. R., Merenstein, D. J., Pot, B.,
Morelli, L., Canani, R. B., Flint, H. J., Salminen, S., Calder, P. C.,
& Sanders, M. E. (2014). Expert consensus document. The
International Scientific Association for Probiotics and
Prebiotics consensus statement on the scope and appropriate
use of the term probiotic. Nature Reviews. Gastroenterology &
Hepatology, 11(8), 506–514. doi:10.1038/nrgastro.2014.66.
Howell, A. B. (2007). Bioactive compounds in cranberries and
their role in prevention of urinary tract infections. Molecular
Nutrition & Food Research, 51(6), 732–737. doi:10.1002/
mnfr.200700038.
Human Microbiome Project Consortium (2012). Structure,
function and diversity of the healthy human microbiome.
Nature, 486(7402), 207–214. doi:10.1038/nature11234.
Krueger, C. G., Reed, J. D., Feliciano, R. P., & Howell, A. B. (2013).
Quantifying and characterizing proanthocyanidins in
cranberries in relation to urinary tract health. Analytical and
Bioanalytical Chemistry, 405(13), 4385–4395. doi:10.1007/s00216-
013-6750-3.
Lamont, R. F., Sobel, J. D., Akins, R. A., Hassan, S. S.,
Chaiworapongsa, T., Kusanovic, J. P., & Romero, R. (2011). The
vaginal microbiome: New information about genital tract
flora using molecular based techniques. BJOG: An International
Journal of Obstetrics and Gynaecology, 118(5), 533–549.
doi:10.1111/j.1471-0528.2010.02840.x.
Ledda, A., Bottari, A., Luzzi, R., Belcaro, G., Hu, S., Dugall, M.,
Hosoi, M., Ippolito, E., Corsi, M., Gizzi, G., Morazzoni, P., Riva,
A., Giacomelli, L., & Togni, S. (2015). Cranberry
supplementation in the prevention of non-severe lower
urinary tract infections: A pilot study. European Review for
Medical and Pharmacological Sciences, 19(1), 77–80.
Liu, Y., Gallardo-Moreno, A. M., Pinzon-Arango, P. A., Reynolds, Y.,
Rodriguez, G., & Camesano, T. A. (2008). Cranberry changes
the physicochemical surface properties of E. coli and
adhesion with uroepithelial cells. Colloids and Surfaces. B,
Biointerfaces, 65(1), 35–42. doi:10.1016/j.colsurfb.2008.02.012.
Ma, B., Forney, L. J., & Ravel, J. (2012). Vaginal microbiome:
Rethinking health and disease. Annual Review of Microbiology,
66, 371–389. doi:10.1146/annurev-micro-092611-150157.
Macklaim, J. M., Clemente, J. C., Knight, R., Gloor, G. B., & Reid, G.
(2015). Changes in vaginal microbiota following antimicrobial
and probiotic therapy. Microbial Ecology in Health and Disease,
26, 27799. doi:10.3402/mehd.v26.27799.
Mastromarino, P., Vitali, B., & Mosca, L. (2013). Bacterial vaginosis:
A review on clinical trials with probiotics. The New
Microbiologica, 36(3), 229–238.
133J o u rna l o f Func t i ona l F ood s 2 5 ( 2 0 1 6 ) 1 2 3 – 1 3 4
Pierre, J. F., Heneghan, A. F., Meudt, J. M., Shea, M. P., Krueger, C.
G., Reed, J. D., Kudsk, K. A., & Shanmuganayagam, D. (2013).
Parenteral nutrition increases susceptibility of ileum to
invasion by E coli. The Journal of Surgical Research, 183(2), 583–
591. doi:10.1016/j.jss.2013.01.054.
Ravel, J., Gajer, P., Abdo, Z., Schneider, G. M., Koenig, S. S.,
McCulle, S. L., Karlebach, S., Gorle, R., Russell, J., Tacket, C. O.,
Brotman, R. M., Davis, C. C., Ault, K., & Ligia Peralta Forney, L.
J. (2011). Vaginal microbiome of reproductive-age women.
Proceedings of the National Academy of Sciences of the United
States of America, 108(Suppl. 1), 4680–4687. doi:10.1073/
pnas.1002611107.
Reid, G., Bruce, A. W., Fraser, N., Heinemann, C., Owen, J., &
Henning, B. (2001). Oral probiotics can resolve urogenital
infections. FEMS Immunology and Medical Microbiology, 30(1),
49–52.
Ritchie, M. L., & Romanuk, T. N. (2012). A meta-analysis of
probiotic efficacy for gastrointestinal diseases. PLoS ONE, 7(4),
e34938. doi:10.1371/journal.pone.0034938.
Rodriguez-Mateos, A., Vauzour, D., Krueger, C. G.,
Shanmuganayagam, D., Reed, J., Calani, L., Mena, P., Del Rio,
D., & Crozier, A. (2014). Bioavailability, bioactivity and impact
on health of dietary flavonoids and related compounds: An
update. Archives of Toxicology, 88(10), 1803–1853. doi:10.1007/
s00204-014-1330-7.
Schwenger, E. M., Tejani, A. M., & Loewen, P. S. (2015). Probiotics
for preventing urinary tract infections in adults and children.
The Cochrane Database of Systematic Reviews, (12), CD008772.
doi:10.1002/14651858.CD008772.pub2.
Sharon, N., & Ofek, I. (2002). Fighting infectious diseases with
inhibitors of microbial adhesion to host tissues. Critical
Reviews in Food Science and Nutrition, 42(3 Suppl.), 267–272.
doi:10.1080/10408390209351914.
Valiquette, L. (2001). Urinary tract infections in women. The
Canadian Journal of Urology, 8(Suppl. 1), 6–12.
Vicariotto, F. (2014). Effectiveness of an association of a cranberry
dry extract, D-mannose, and the two microorganisms
Lactobacillus plantarum LP01 and Lactobacillus paracasei
LPC09 in women affected by cystitis: A pilot study. Journal of
Clinical Gastroenterology, 48(Suppl. 1), S96–S101. doi:10.1097/
MCG.0000000000000224.
Wiles, T. J., Kulesus, R. R., & Mulvey, M. A. (2008). Origins and
virulence mechanisms of uropathogenic Escherichia coli.
Experimental and Molecular Pathology, 85(1), 11–19. doi:10.1016/
j.yexmp.2008.03.007.
134 J o u rna l o f Func t i ona l F ood s 2 5 ( 2 0 1 6 ) 1 2 3 – 1 3 4
